Skip to main content
. Author manuscript; available in PMC: 2021 Oct 13.
Published in final edited form as: Mol Psychiatry. 2020 Sep 14;26(7):3292–3301. doi: 10.1038/s41380-020-00878-1

Figure 3.

Figure 3.

The relationship between changes in ketamine and peripheral inflammation (measured by C-reactive protein (CRP) one day post-infusion) with changes in functional connectivity (measured two days post-infusion) between the ventral rostral putamen (VRP) and right orbitofrontal cortex (OFC). Data are plotted separately for healthy volunteers (HVs; p=0.007) and individuals with treatment-resistant depression (TRD; p=0.77). Δ: ketamine minus placebo